https://www.selleckchem.com/products/erastin2.html
pplication of AF treatment algorithms to cancer populations. The use of transcatheter aortic valve replacement (TAVR) in cancer survivors and patients with active cancer (AC) in cancer survivors and patients with active cancer (AC) is expanding, suggesting a need to adjust the indications and risk assessment pre-TAVR. The purpose of this study was to determine the impact of cancer on peri-procedural complications and survival in a long-term, single-center cohort of patients treated with TAVR. Patients treated with TAVR between January
Like
Comment
Share
